Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Bionic Eye Market 

5.1. COVID-19 Landscape: Bionic Eye Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Bionic Eye Market, By Type

8.1. Bionic Eye Market Revenue and Volume, by Type, 2023-2032

8.1.1 External Eye

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Implanted Eye

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Bionic Eye Market, By Technology

9.1. Bionic Eye Market Revenue and Volume, by Technology, 2023-2032

9.1.1. Electronic

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Mechanical

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Bionic Eye Market, By End Users 

10.1. Bionic Eye Market Revenue and Volume, by End Users, 2023-2032

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Ophthalmic Clinics

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Bionic Eye Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.1.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.1.4.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.1.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.1.5.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.2.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.2.4.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.2.5.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.2.6.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.2.7.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.2.7.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.3.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.3.4.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.3.5.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.3.6.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.3.7.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.3.7.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.4.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.4.4.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.4.5.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.6.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.4.6.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.4.7.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.4.7.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.5.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.4.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.5.4.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Type (2020-2032)

11.5.5.2. Market Revenue and Volume Forecast, by Technology (2020-2032)

11.5.5.3. Market Revenue and Volume Forecast, by End Users (2020-2032)

Chapter 12. Company Profiles

12.1. Second Sight Medical Products, Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Pixium Vision

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Retina Implant AG

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Bionic Vision Australia

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. iBionics

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Nano Retina

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. The Johns Hopkins University

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. MicroOptical

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bionic Eye Technologies

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Optobionics Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms